Follow
W. B. Wang
Title
Cited by
Cited by
Year
Method and system for examining biological materials using low power CW excitation raman spectroscopy
RR Alfano, W Wang
US Patent 6,151,522, 2000
2342000
Changes of collagen and nicotinamide adenine dinucleotide in human cancerous and normal prostate tissues studied using native fluorescence spectroscopy with selective …
Y Pu, W Wang, G Tang, RR Alfano
Journal of biomedical optics 15 (4), 047008-047008-5, 2010
109*2010
Near infrared spectroscopy and imaging to probe differences in water content in normal and cancer human prostate tissues
JH Ali, WB Wang, M Zevallos, RR Alfano
Technology in cancer research & treatment 3 (5), 491-497, 2004
1032004
Backilluminated GaN/AlGaN heterojunction ultraviolet photodetector with high internal gain
SK Zhang, WB Wang, I Shtau, F Yun, L He, H Morkoç, X Zhou, M Tamargo, ...
Applied physics letters 81 (25), 4862-4864, 2002
1032002
Method and system for examining biological materials using low power CW excitation Raman spectroscopy
RR Alfano, W Wang
US Patent 6,560,478, 2003
872003
Apparatus for enhancing the visibility of a luminous object inside tissue and methods for same
RR Alfano, SG Demos, W Wang, J Ali
US Patent 6,280,386, 2001
832001
Spectral polarization imaging of human prostate cancer tissue using a near-infrared receptor-targeted contrast agent
Y Pu, WB Wang, GC Tang, F Zeng, S Achilefu, JH Vitenson, I Sawczuk, ...
Technology in cancer research & treatment 4 (4), 429-436, 2005
792005
Deep transmission of Laguerre–Gaussian vortex beams through turbid scattering media
WB Wang, R Gozali, L Shi, L Lindwasser, RR Alfano
Optics letters 41 (9), 2069-2072, 2016
782016
Detecting human cancer through spectral optical imaging using key water absorption wavelengths
RR Alfano, JH Ali, W Wang, M Zevallos
US Patent 7,706,862, 2010
75*2010
Imaging of objects in turbid media based upon the preservation of polarized luminescence emitted from contrast agents
RR Alfano, SG Demos, W Wang
US Patent 6,091,983, 2000
712000
Native fluorescence spectra of human cancerous and normal breast tissues analyzed with non-negative constraint methods
Y Pu, W Wang, Y Yang, RR Alfano
Applied optics 52 (6), 1293-1301, 2013
632013
Observation of the 1P excitonic states in Cd (S, Se)-glass quantum dots
K Shum, WB Wang, RR Alfano, KM Jones
Physical review letters 68 (26), 3904, 1992
621992
Time-resolved and nonlinear optical imaging for medical applications.
RR Alfano, SG Demos, P Galland, SK Gayen, Y Guo, PP Ho, X Liang, ...
Annals of the New York Academy of Sciences 838, 14-28, 1998
591998
Stokes shift spectroscopy highlights differences of cancerous and normal human tissues
Y Pu, W Wang, Y Yang, RR Alfano
Optics Letters 37 (16), 3360-3362, 2012
582012
Determination of Optical Coefficients and Fractal Dimensional Parameters of Cancerous and Normal Prostate Tissues
Y Pu, W Wang, M AL-Rubaiee, SK Gayen, M Xu
Applied Spectroscopy 66 (7), 828-834, 2012
572012
Time-resolved fluorescence polarization dynamics and optical imaging of Cytate: a prostate cancer receptor-targeted contrast agent
Y Pu, WB Wang, BB Das, S Achilefu, RR Alfano
Applied Optics 47 (13), 2281-2289, 2008
552008
Backilluminated ultraviolet photodetector based on GaN/AlGaN multiple quantum wells
SK Zhang, WB Wang, F Yun, L He, H Morkoç, X Zhou, M Tamargo, ...
Applied physics letters 81 (24), 4628-4630, 2002
512002
Optical detection of meat spoilage using fluorescence spectroscopy with selective excitation wavelength
Y Pu, W Wang, RR Alfano
Applied Spectroscopy 67 (2), 210-213, 2013
502013
Stokes shift spectroscopic analysis of multifluorophores for human cancer detection in breast and prostate tissues
Y Pu, W Wang, Y Yang, RR Alfano
Journal of Biomedical Optics 18 (1), 017005-017005, 2013
492013
Native fluorescence spectroscopic evaluation of chemotherapeutic effects on malignant cells using nonnegative matrix factorization analysis
Y Pu, GC Tang, WB Wang, HE Savage, SP Schantz, RR Alfano
Technology in cancer research & treatment 10 (2), 113-120, 2011
492011
The system can't perform the operation now. Try again later.
Articles 1–20